Baak-Baak Carlos M, Cigarroa-Toledo Nohemi, Pinto-Castillo Jose F, Cetina-Trejo Rosa C, Torres-Chable Oswaldo, Blitvich Bradley J, Garcia-Rejon Julian E
Laboratorio de Arbovirología, Centro de Investigaciones Regionales "Dr. Hideyo Noguchi," Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
Laboratorio de Biología Celular, Centro de Investigaciones Regionales "Dr. Hideyo Noguchi," Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
Am J Trop Med Hyg. 2022 Mar 14;106(5):1515-21. doi: 10.4269/ajtmh.21-0409.
Dengue cases and deaths occur frequently in Mexico, although the trend is not uniform across the country. We performed a Spatio-temporal analysis of dengue cases and deaths in Mexico from 2007 to 2020, and clustered states according to whether there was a low, moderate, or high risk of dengue. A total of 501,600 confirmed dengue cases were registered from 2007 to 2020, with 378,122 cases classified as dengue fever (DF) and 123,478 cases classified as dengue hemorrhagic fever (DHF). For each confirmed case, there were 4.68 probable cases. There were 1,230 dengue deaths, with highest numbers reported in 2009, 2012, 2013, and 2019. The number of deaths had a significant correlation (P ≤ 0.01) with DF (r = 0.82), DHF (r = 0.94), and probable dengue cases (r = 0.84). States were clustered using Machine Learning technique according to select indices associated with dengue. Cluster 1 (low risk) primarily contained states in the northwest, northcentral, and east. Cluster 2 (moderate risk) includes states in the northeast. Cluster 3 (high risk) mostly contained coastal states in the southeast, southwest, and west. The generation of the clusters was supported by the Kruskal-Wallis test. A significant difference was found in the incidence, mortality rates, and case-fatality rates of dengue among the clusters (P ≤ 0.01). Notably, cluster 3 contributed 71.4% of the confirmed cases and 89.2% of the deaths. Public health and vector control strategies designed to mitigate the burden of dengue in Mexico should consider the states in cluster 3 as high priority areas.
登革热病例和死亡在墨西哥频繁发生,尽管全国趋势并不统一。我们对2007年至2020年墨西哥的登革热病例和死亡进行了时空分析,并根据登革热低、中、高风险对各州进行了聚类。2007年至2020年共登记了501,600例确诊登革热病例,其中378,122例归类为登革热发热(DF),123,478例归类为登革出血热(DHF)。每例确诊病例对应4.68例疑似病例。有1230例登革热死亡病例,2009年、2012年、2013年和2019年报告的死亡人数最多。死亡人数与DF(r = 0.82)、DHF(r = 0.94)和疑似登革热病例(r = 0.84)有显著相关性(P≤0.01)。根据与登革热相关的选定指标,使用机器学习技术对各州进行聚类。第1组(低风险)主要包括西北部、中北部和东部的州。第2组(中等风险)包括东北部的州。第3组(高风险)主要包括东南部、西南部和西部的沿海州。聚类的生成得到了Kruskal-Wallis检验的支持。各聚类之间登革热的发病率、死亡率和病死率存在显著差异(P≤0.01)。值得注意的是,第3组贡献了71.4%的确诊病例和89.2%的死亡病例。旨在减轻墨西哥登革热负担的公共卫生和病媒控制策略应将第3组的州视为高度优先区域。